SUNNYVALE, Calif. -- Scios, Inc. today announced that the lead article and editorial published in this week's issue of the Journal of the American Medical Association (JAMA) support the use of the company's flagship product, Natrecor(R) (nesiritide), for the treatment of acutely decompensated ...